Mondelez International, Inc.

Mondelez International’s 2026 10-Q, filed April 28, 2026, offers a look at recent financial trends, notably an increase in net revenues — total sales after returns and discounts — to $10,080 million for the three months ended March 31, 2026, up from $9,313 million in the prior year’s comparable period. This top-line growth contributed to an improved gross profit — revenue minus the cost of goods sold — which reached $2,803 million compared to $2,430 million in the same period of 2025. The filing’s Item 7, Management’s Discussion and Analysis, opens with a standard but legally significant section on “Forward-Looking Statements,” clarifying that “All statements other than statements of historical fact are ‘forward-looking statements’.” This sets the interpretive stage for any future projections within the document.

A quantitative forensic assessment of this filing is, by necessity, incomplete. The Beneish M-Score — Beneish’s 1999 eight-ratio earnings-manipulation detector — is not available for this period. Similarly, Altman’s Z″ — Altman’s 1968 bankruptcy-distress index — which gauges a company’s likelihood of financial distress, is also absent. The Piotroski F-Score — Piotroski’s 2000 9-point fundamental strength scan — designed to identify financially healthy firms, is likewise unavailable. Finally, the Fog Index — Gunning’s 1952 readability score, where 18+ indicates obfuscatory prose — cannot be calculated from the provided excerpts. The absence of these standard metrics limits the ability to detect potential accounting red flags or assess fundamental strength through established models.

The MD&A’s initial focus on “Forward-Looking Statements” is a common, yet critical, disclosure for readers. The filing explicitly states that all statements other than statements of historical fact are ‘forward-looking statements’ for purposes of federal and state securities laws. This standard language serves to legally protect management’s projections, encompassing any statements regarding future earnings, revenue, capital expenditures, or new products, as outlined in Item 7. It signals to the reader that any discussion of future performance or strategy carries inherent uncertainty and is not a guarantee. Its placement at the outset of the MD&A underscores the legal framework governing the interpretation of management’s narrative, advising caution when assessing future-oriented claims.

This reading, constrained by the provided excerpts and the absence of key forensic scores, offers a limited perspective on MDLZ. The filing indicates recent growth in net revenues and gross profit, but without the Beneish M-Score, Altman Z″, Piotroski F-Score, or Fog Index, a deeper quantitative assessment of earnings quality, financial distress, fundamental strength, or readability remains beyond reach. Consequently, the filing itself, as presented, cannot definitively answer whether the security is mispriced, as that requires a broader market and fundamental analysis. It does, however, provide a clear legal context for interpreting management’s forward-looking commentary. A comprehensive view would necessitate access to the full document and all relevant financial data to form an independent judgment.